Overview

Guangzhou Yingsaite Biotechnology Co., Ltd. is a globally leading research and development driven feed additive enterprise founded by Dr. Peng Xianfeng in 2008. The company focuses on the research and development of high-value patented compound feed additives and new animal medicine products. It has established chemical and comprehensive biology laboratories in the Guangzhou Science City International Enterprise Incubator and the South China New Drug Creation Center, nearly 300 acres of animal testing ground in Nanxiong, Guangdong, and a 10000 square meter raw material factory and a 10000 square meter feed additive preparation factory in the Nanxiong Fine Chemical Park, Guangdong (which has passed both ISO9001 quality management system and ISO22000 food safety system certifications). Yingsaite has gathered nearly 30 professional R&D talents from multiple disciplines, including veterinary pharmacology, preventive veterinary medicine, pharmaceutical chemistry, chemical processes, animal nutrition, drug analysis, toxicology, and genetic engineering. In the feed additive and animal protection industry in China, Yingsaite is the first to carry out molecular design (including lead compound screening and optimization), synthesis, and screening testing of multiple innovative feed additives and veterinary drug compounds. As of June 2023, INSET has submitted a total of 236 invention patent applications at home and abroad, with 102 patents granted, including 71 in China, 31 overseas, and PCT32. Yingsaite was recognized as a national high-tech enterprise in 2014 and was approved by the Guangdong Provincial Department of Science and Technology to establish the Guangdong New Feed Additive Discovery Engineering Technology Research Center in 2017. In 2021, it was rated as a leading agricultural enterprise in Guangzhou and a specialized, refined, and new small and medium-sized enterprise in Guangdong Province. In December 2020, Inset signed a cooperation agreement with the First Multinational Animal Protection Company of the United States for a total price of 4.5 million US dollars on the invention patent of anti coccidiosis compounds, making it the first enterprise in China's animal husbandry and veterinary industry to achieve a patent technology License Out.